カテゴリー： Market Monitor Global, 世界, 医療/バイオ

抗凝固薬回復薬の世界市場見通し2023年-2029年

◆英語タイトル：Anticoagulant Reversal Medicine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5674）

◆商品コード：MMG23JU5674
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：66
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Anticoagulant Reversal Medicine Market 調査レポートは次の情報を含め、グローバルにおけるの抗凝固薬回復薬市場規模と予測を収録しています。・世界の抗凝固薬回復薬市場：売上、2018年-2023年、2024年-2029年
・世界の抗凝固薬回復薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の抗凝固薬回復薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プロトロンビン複合体濃縮物」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

抗凝固薬回復薬のグローバル主要企業は、Amneal Pharmaceuticals、 Bausch Health Companies、 Boehringer Ingelheim、 CSL、 Fresenius Kabi、 Octapharma、 Perosphere Pharmaceuticals、 Portola Pharmaceuticals、 Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、抗凝固薬回復薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の抗凝固薬回復薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の抗凝固薬回復薬市場：タイプ別市場シェア、2022年
・プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他

世界の抗凝固薬回復薬市場：用途別、2018年-2023年、2024年-2029年
世界の抗凝固薬回復薬市場：用途別市場シェア、2022年
・病院薬局、小売薬局、オンライン薬局

世界の抗凝固薬回復薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の抗凝固薬回復薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における抗凝固薬回復薬のグローバル売上、2018年-2023年
・主要企業における抗凝固薬回復薬のグローバル売上シェア、2022年
・主要企業における抗凝固薬回復薬のグローバル販売量、2018年-2023年
・主要企業における抗凝固薬回復薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Amneal Pharmaceuticals、 Bausch Health Companies、 Boehringer Ingelheim、 CSL、 Fresenius Kabi、 Octapharma、 Perosphere Pharmaceuticals、 Portola Pharmaceuticals、 Pfizer

*************************************************************

・調査・分析レポートの概要
抗凝固薬回復薬市場の定義
市場セグメント
世界の抗凝固薬回復薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の抗凝固薬回復薬市場規模
世界の抗凝固薬回復薬市場規模：2022年 VS 2029年
世界の抗凝固薬回復薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの抗凝固薬回復薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の抗凝固薬回復薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：プロトロンビン複合体濃縮物、凝固因子、モノクローナル抗体、フィトナジオン、その他
抗凝固薬回復薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局、オンライン薬局
抗凝固薬回復薬の用途別グローバル売上・予測

・地域別市場分析
地域別抗凝固薬回復薬市場規模 2022年と2029年
地域別抗凝固薬回復薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Amneal Pharmaceuticals、 Bausch Health Companies、 Boehringer Ingelheim、 CSL、 Fresenius Kabi、 Octapharma、 Perosphere Pharmaceuticals、 Portola Pharmaceuticals、 Pfizer
...

Anticoagulant reversal medicine required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.
This report aims to provide a comprehensive presentation of the global market for Anticoagulant Reversal Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anticoagulant Reversal Medicine. This report contains market size and forecasts of Anticoagulant Reversal Medicine in global, including the following market information:
Global Anticoagulant Reversal Medicine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anticoagulant Reversal Medicine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Prothrombin Complex Concentrates Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anticoagulant Reversal Medicine include Amneal Pharmaceuticals, Bausch Health Companies, Boehringer Ingelheim, CSL, Fresenius Kabi, Octapharma, Perosphere Pharmaceuticals, Portola Pharmaceuticals and Pfizer, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anticoagulant Reversal Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anticoagulant Reversal Medicine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, by Type, 2022 (%)
Prothrombin Complex Concentrates
Coagulation Factors
Monoclonal Antibodies
Phytonadione
Others
Global Anticoagulant Reversal Medicine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Anticoagulant Reversal Medicine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anticoagulant Reversal Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anticoagulant Reversal Medicine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anticoagulant Reversal Medicine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amneal Pharmaceuticals
Bausch Health Companies
Boehringer Ingelheim
CSL
Fresenius Kabi
Octapharma
Perosphere Pharmaceuticals
Portola Pharmaceuticals
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anticoagulant Reversal Medicine, market overview.
Chapter 2: Global Anticoagulant Reversal Medicine market size in revenue.
Chapter 3: Detailed analysis of Anticoagulant Reversal Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anticoagulant Reversal Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Anticoagulant Reversal Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anticoagulant Reversal Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anticoagulant Reversal Medicine Overall Market Size
2.1 Global Anticoagulant Reversal Medicine Market Size: 2022 VS 2029
2.2 Global Anticoagulant Reversal Medicine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anticoagulant Reversal Medicine Players in Global Market
3.2 Top Global Anticoagulant Reversal Medicine Companies Ranked by Revenue
3.3 Global Anticoagulant Reversal Medicine Revenue by Companies
3.4 Top 3 and Top 5 Anticoagulant Reversal Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anticoagulant Reversal Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anticoagulant Reversal Medicine Players in Global Market
3.6.1 List of Global Tier 1 Anticoagulant Reversal Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Anticoagulant Reversal Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Anticoagulant Reversal Medicine Market Size Markets, 2022 & 2029
4.1.2 Prothrombin Complex Concentrates
4.1.3 Coagulation Factors
4.1.4 Monoclonal Antibodies
4.1.5 Phytonadione
4.1.6 Others
4.2 By Type – Global Anticoagulant Reversal Medicine Revenue & Forecasts
4.2.1 By Type – Global Anticoagulant Reversal Medicine Revenue, 2018-2023
4.2.2 By Type – Global Anticoagulant Reversal Medicine Revenue, 2024-2029
4.2.3 By Type – Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Anticoagulant Reversal Medicine Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application – Global Anticoagulant Reversal Medicine Revenue & Forecasts
5.2.1 By Application – Global Anticoagulant Reversal Medicine Revenue, 2018-2023
5.2.2 By Application – Global Anticoagulant Reversal Medicine Revenue, 2024-2029
5.2.3 By Application – Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Anticoagulant Reversal Medicine Market Size, 2022 & 2029
6.2 By Region – Global Anticoagulant Reversal Medicine Revenue & Forecasts
6.2.1 By Region – Global Anticoagulant Reversal Medicine Revenue, 2018-2023
6.2.2 By Region – Global Anticoagulant Reversal Medicine Revenue, 2024-2029
6.2.3 By Region – Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Anticoagulant Reversal Medicine Revenue, 2018-2029
6.3.2 US Anticoagulant Reversal Medicine Market Size, 2018-2029
6.3.3 Canada Anticoagulant Reversal Medicine Market Size, 2018-2029
6.3.4 Mexico Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Anticoagulant Reversal Medicine Revenue, 2018-2029
6.4.2 Germany Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.3 France Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.4 U.K. Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.5 Italy Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.6 Russia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Anticoagulant Reversal Medicine Market Size, 2018-2029
6.4.8 Benelux Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Anticoagulant Reversal Medicine Revenue, 2018-2029
6.5.2 China Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.3 Japan Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.4 South Korea Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.5.6 India Anticoagulant Reversal Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Anticoagulant Reversal Medicine Revenue, 2018-2029
6.6.2 Brazil Anticoagulant Reversal Medicine Market Size, 2018-2029
6.6.3 Argentina Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Anticoagulant Reversal Medicine Revenue, 2018-2029
6.7.2 Turkey Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.3 Israel Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Anticoagulant Reversal Medicine Market Size, 2018-2029
6.7.5 UAE Anticoagulant Reversal Medicine Market Size, 2018-2029
7 Anticoagulant Reversal Medicine Companies Profiles
7.1 Amneal Pharmaceuticals
7.1.1 Amneal Pharmaceuticals Company Summary
7.1.2 Amneal Pharmaceuticals Business Overview
7.1.3 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.1.4 Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.1.5 Amneal Pharmaceuticals Key News & Latest Developments
7.2 Bausch Health Companies
7.2.1 Bausch Health Companies Company Summary
7.2.2 Bausch Health Companies Business Overview
7.2.3 Bausch Health Companies Anticoagulant Reversal Medicine Major Product Offerings
7.2.4 Bausch Health Companies Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.2.5 Bausch Health Companies Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Anticoagulant Reversal Medicine Major Product Offerings
7.3.4 Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 CSL
7.4.1 CSL Company Summary
7.4.2 CSL Business Overview
7.4.3 CSL Anticoagulant Reversal Medicine Major Product Offerings
7.4.4 CSL Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.4.5 CSL Key News & Latest Developments
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Company Summary
7.5.2 Fresenius Kabi Business Overview
7.5.3 Fresenius Kabi Anticoagulant Reversal Medicine Major Product Offerings
7.5.4 Fresenius Kabi Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.5.5 Fresenius Kabi Key News & Latest Developments
7.6 Octapharma
7.6.1 Octapharma Company Summary
7.6.2 Octapharma Business Overview
7.6.3 Octapharma Anticoagulant Reversal Medicine Major Product Offerings
7.6.4 Octapharma Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.6.5 Octapharma Key News & Latest Developments
7.7 Perosphere Pharmaceuticals
7.7.1 Perosphere Pharmaceuticals Company Summary
7.7.2 Perosphere Pharmaceuticals Business Overview
7.7.3 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.7.4 Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.7.5 Perosphere Pharmaceuticals Key News & Latest Developments
7.8 Portola Pharmaceuticals
7.8.1 Portola Pharmaceuticals Company Summary
7.8.2 Portola Pharmaceuticals Business Overview
7.8.3 Portola Pharmaceuticals Anticoagulant Reversal Medicine Major Product Offerings
7.8.4 Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.8.5 Portola Pharmaceuticals Key News & Latest Developments
7.9 Pfizer
7.9.1 Pfizer Company Summary
7.9.2 Pfizer Business Overview
7.9.3 Pfizer Anticoagulant Reversal Medicine Major Product Offerings
7.9.4 Pfizer Anticoagulant Reversal Medicine Revenue in Global Market (2018-2023)
7.9.5 Pfizer Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Anticoagulant Reversal Medicine Market Opportunities & Trends in Global Market
Table 2. Anticoagulant Reversal Medicine Market Drivers in Global Market
Table 3. Anticoagulant Reversal Medicine Market Restraints in Global Market
Table 4. Key Players of Anticoagulant Reversal Medicine in Global Market
Table 5. Top Anticoagulant Reversal Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anticoagulant Reversal Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anticoagulant Reversal Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anticoagulant Reversal Medicine Product Type
Table 9. List of Global Tier 1 Anticoagulant Reversal Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anticoagulant Reversal Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anticoagulant Reversal Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anticoagulant Reversal Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anticoagulant Reversal Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anticoagulant Reversal Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anticoagulant Reversal Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anticoagulant Reversal Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2024-2029
Table 30. Amneal Pharmaceuticals Company Summary
Table 31. Amneal Pharmaceuticals Anticoagulant Reversal Medicine Product Offerings
Table 32. Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 33. Amneal Pharmaceuticals Key News & Latest Developments
Table 34. Bausch Health Companies Company Summary
Table 35. Bausch Health Companies Anticoagulant Reversal Medicine Product Offerings
Table 36. Bausch Health Companies Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 37. Bausch Health Companies Key News & Latest Developments
Table 38. Boehringer Ingelheim Company Summary
Table 39. Boehringer Ingelheim Anticoagulant Reversal Medicine Product Offerings
Table 40. Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 41. Boehringer Ingelheim Key News & Latest Developments
Table 42. CSL Company Summary
Table 43. CSL Anticoagulant Reversal Medicine Product Offerings
Table 44. CSL Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 45. CSL Key News & Latest Developments
Table 46. Fresenius Kabi Company Summary
Table 47. Fresenius Kabi Anticoagulant Reversal Medicine Product Offerings
Table 48. Fresenius Kabi Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 49. Fresenius Kabi Key News & Latest Developments
Table 50. Octapharma Company Summary
Table 51. Octapharma Anticoagulant Reversal Medicine Product Offerings
Table 52. Octapharma Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 53. Octapharma Key News & Latest Developments
Table 54. Perosphere Pharmaceuticals Company Summary
Table 55. Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Product Offerings
Table 56. Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 57. Perosphere Pharmaceuticals Key News & Latest Developments
Table 58. Portola Pharmaceuticals Company Summary
Table 59. Portola Pharmaceuticals Anticoagulant Reversal Medicine Product Offerings
Table 60. Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 61. Portola Pharmaceuticals Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Anticoagulant Reversal Medicine Product Offerings
Table 64. Pfizer Anticoagulant Reversal Medicine Revenue (US$, Mn) & (2018-2023)
Table 65. Pfizer Key News & Latest Developments
List of Figures
Figure 1. Anticoagulant Reversal Medicine Segment by Type in 2022
Figure 2. Anticoagulant Reversal Medicine Segment by Application in 2022
Figure 3. Global Anticoagulant Reversal Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anticoagulant Reversal Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anticoagulant Reversal Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anticoagulant Reversal Medicine Revenue in 2022
Figure 8. By Type - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 16. US Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 20. Germany Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 28. China Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anticoagulant Reversal Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anticoagulant Reversal Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. Amneal Pharmaceuticals Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Bausch Health Companies Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Boehringer Ingelheim Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. CSL Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Fresenius Kabi Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Octapharma Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Perosphere Pharmaceuticals Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Portola Pharmaceuticals Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pfizer Anticoagulant Reversal Medicine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 抗凝固薬回復薬の世界市場見通し2023年-2029年(Anticoagulant Reversal Medicine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

抗凝固薬回復薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp